merck's historical efforts in infectious diseases and against covid-19

We're rising to the COVID-19 Challenge

From developing vaccines for Ebola to pioneering research in HIV, Merck has been combating global health threats caused by infectious diseases for over a century.

The COVID-19 pandemic is an unrivaled global health challenge. Our decades of research experience in vaccines and treatments for infections mean we have a duty to help make a difference.

merck and pharma companies working together

United for Research

We committed to developing preventative medicines and treatments for COVID-19 as soon as it was known as a pandemic. Successfully fighting it requires global partnerships among countries, companies, and more.

Here at Merck, we are also studying other approaches to ending the COVID-19 pandemic, including treatments and preventative medicines that are not vaccines. We are optimistic our industry’s efforts will create new treatments at a faster rate to fight this pandemic.

We value patient diversity

The rise of the COVID-19 pandemic has highlighted how much communities of color can be overly impacted by global health issues. We must learn how safe and effective (how well they work) our treatments are for all people around the world.

a diverse group of individuals wearing face masks to do their part to slow the spread of COVID-19 a diverse group of individuals wearing face masks to do their part to slow the spread of COVID-19

How we include diversity

We’ve taken steps to close diversity gaps in our clinical trials, including to:

  • Educate our team on diversity issues with programs such as our Global Diversity and Inclusion Center of Excellence
  • Partner with research sites that include a diverse mix of investigators (researchers) to grow programs that support the research study education of minority Principal Investigators and patients
  • Work with research sites to make sure they reach out to minorities to take part in the trials
  • Check research data and make changes to ensure diverse groups of people take part
  • Create resources for research sites that can improve health knowledge and communication (health literacy) among diverse communities

Diversity is important to us. That’s why, at Merck, we’ll continue to foster discussion, create awareness, and empower research sites to recruit patients based on the impact of diseases in groups that might otherwise be under-represented in our research.

We need your help to fight COVID-19.

Get Involved